Can you get live vaccines while on Cosentyx?
No, avoid live vaccines during Cosentyx (secukinumab) treatment. The drug suppresses the immune system by blocking IL-17A, increasing infection risk from live vaccines like MMR, varicella, or oral polio, which contain weakened live virus.[1] Prescribing information states: do not administer live vaccines concurrently.
What about live vaccines after stopping Cosentyx?
Wait until immune function recovers before getting live vaccines. No fixed timeline exists—recovery varies by patient, dose, and duration of therapy. Guidelines recommend screening for immune response or delaying 4-6 months post-discontinuation, but consult a doctor for individual assessment via antibody titers or clinical judgment.[1][2]
Why the higher risk with live vaccines specifically?
Live vaccines replicate in the body to build immunity, but Cosentyx impairs this process, potentially causing uncontrolled viral spread or poor vaccine efficacy. Inactivated vaccines (e.g., flu shot, Tdap) or mRNA vaccines (e.g., COVID-19) are generally safe during treatment.[1]
How soon can you restart Cosentyx after a live vaccine?
Delay Cosentyx initiation for at least 4 weeks after live vaccination to allow immune response development. Shorter intervals risk blunting the vaccine's effect.[1]
What do real-world studies and patient reports show?
Clinical trials excluded live vaccines, but post-marketing data reports rare disseminated infections (e.g., varicella) in patients receiving them during IL-17 inhibitors. Rheumatology guidelines (e.g., ACR) advise against live vaccines in active biologic users; some patients report successful vaccination post-washout without issues, but risks persist in immunocompromised cases.[2][3]
Alternatives for vaccination during Cosentyx treatment
Opt for non-live options:
- Influenza: Injectable inactivated version.
- Shingles: Recombinant zoster vaccine (Shingrix), preferred over live Zostavax.
- Pneumococcal: Inactivated conjugate vaccine (PCV20 or PCV15).
Discuss with your provider for catch-up schedules.[2]
[1] Cosentyx (secukinumab) Prescribing Information, Novartis, latest update 2023. https://www.novartis.com/us-en/sites/novartis_us/files/cosentyx.pdf
[2] American College of Rheumatology Guidelines for Vaccinations in Adults with Rheumatic Diseases, 2021. https://rheumatology.org/vaccination-guidelines
[3] DrugPatentWatch.com (Cosentyx safety data summaries). https://www.drugpatentwatch.com/p/tradename/COSENTYX